Tirzepatide 60mg
Dual-pathway GIP/GLP-1 receptor agonist research compound
$15 flat shipping · Free over $199.00
Ships in 1–2 business days · FedEx 2Day
Specification
- Purity
- ≥99% (HPLC/MS)
- Size
- 60mg
- Molecular Weight
- 4,813.5 g/mol
- CAS
- 2023788-19-2
- Catalog No.
- PG-TIRZ-060
- Form
- Lyophilized powder
- Storage
- -20°C, protect from light
Overview
Tirzepatide is a 39-amino-acid synthetic peptide engineered as a dual agonist with balanced activity at two receptor targets, carrying a C20 fatty diacid moiety supporting albumin binding.
Mechanism
Dual-pathway GIP/GLP-1 receptor agonist research compound
Research Note
Studied for the synergistic signaling that emerges from co-activating two pathways at once — receptor binding balance, biased agonism, and downstream cascade dynamics single-pathway agonists do not reproduce.
References
- [1]Coskun T. et al. (2018). Mol Metabol 18:3–14
- [2]Frias J.P. et al. (2021). NEJM 385:503–515
Storage & Handling
Storage
Store sealed at -20°C, protected from light and moisture, until laboratory use. Reseal and return to cold storage promptly after handling.
Handling
Supplied as a lyophilized powder intended for in-vitro laboratory use. Handle with standard laboratory PPE and technique appropriate to your research protocol.
Stability
Stable as a lyophilized powder under recommended storage conditions through the labeled use-by date. Post-preparation stability depends on the buffer and conditions selected by the researcher.
Frequently Asked Questions
For Research Use Only. Not for human or veterinary use. Products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.